Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein S3A pseudogene 15 (RPS3AP15) is one of multiple processed pseudogenes derived from the parent gene RPS3A, which encodes a component of the 40S ribosomal subunit involved in protein synthesis[3][5][7]. Pseudogenes like RPS3AP15 are non-coding genomic elements—arising from duplication, retrotransposition, or processing—that generally do not produce functional proteins. Some pseudogenes can have regulatory functions, such as acting as competing endogenous RNAs (ceRNAs), miRNA decoys, or influencing posttranscriptional regulation of their parental genes[2]. However, there is no published evidence for any specific biological or disease role for RPS3AP15, nor is it considered a therapeutic target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein S3A pseudogene 15 (RPS3AP15).